Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 3 of 3

TitlePrioritisation programmeDecisionDecision date
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (managed access review of TA1023) [ID6653]None selectedAwaiting decision
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments [TSID11969]None selectedNot selected
MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270)None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All